Hormel Foods Corporation (HRL)

Rating: HOLD

HOLD (5-tier) · income compounder · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +3% vs spot
• Monte Carlo median implies -8% vs spot
• DCF fair value implies -34% vs spot — but this is terminal-value sensitive (exit-multiple $16 vs Gordon $21, 29% apart), so it carries less weight
• Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -59% vs spot
• Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $24.82 spot on 17-times forward earnings, the market prices Hormel roughly in line with the packaged-food median: a low-growth, dividend-paying protein and centre-store book with no re-rating priced in and no imminent break. The engine broadly agrees. Its probability-weighted target of $25.33 sits a fraction above spot, and the triangulated view leans on the base scenario, where price/mix offsets soft volume and non-GAAP operating margin rebuilds toward 8.8%. Against that, the DCF anchor is more cautious at roughly $18 per share, held back by a capex glidepath rising toward 4% of revenue while incremental returns on capital stay thin near 4%. The rating is HOLD because the probability-weighted target barely clears spot and the DCF sits below it, leaving no margin of safety either way. The single most damaging risk is structural: if GLP-1-led calorie deflation and private-label switching prove durable rather than cyclical, both the earnings base and the multiple compress together, and the 24% structural scenario carries a target near $11.

The dashboard below is the whole argument on one page: spot ($25) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear case is the base scenario souring into structural impairment. GLP-1 adoption is not a passing headwind; it lowers the calorie budget across the exact protein and centre-store categories Hormel over-indexes to, while grocers keep expanding private-label to defend traffic. If branded volume declines compound for several years, price/mix can no longer offset them, plants run under-absorbed, and non-GAAP margin drifts below the 8% floor. Earnings and the multiple then de-rate together, exactly the mechanism the structural scenario models toward an $11 target below the 52-week low. A $2.0bn net-debt position and a rising capex schedule leave little room to defend the dividend if free cash flow slips below the payout.

Key Debate

Gross Margin explains 72% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.67 vs analyst floor +0.00 → delta +0.67 (n=22 mgmt / 19 Q&A; 95th pctile across the S&P book, z +1.7).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

News (last 365d, 1000 articles): avg ticker sentiment +0.08 (bullish 20% / bearish 12%)

Scenario Analysis

The tree runs from a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($10) to a 'Bull — Margin Recovery / Re-Rate' bull case ($45); the probability-weighted blend (PWEV $25) is +3% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — GLP-1 / Private-Label Erosion (24%, $10). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 10.87; probability: 0.24.
• Volume / Cost Recession (18%, $21). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising. Drivers — implied_target: 20.72; probability: 0.18.
• Base — Price/Mix Offsets Volume (32%, $28). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns. Drivers — implied_target: 28.08; probability: 0.32.
• Growth — Snacking + Premiumization (18%, $37). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 36.05; probability: 0.18.
• Bull — Margin Recovery / Re-Rate (8%, $45). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery. Drivers — implied_target: 43.97; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $23 and 45% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (72% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 14x terminal FCF multiple → $16. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.56x) implies $25. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 110% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Food Bev

This name sits in the Consumer Staples — Food Bev as a packaged_food. packaged-food volume + price/mix vs private-label + GLP-1 + input costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)

Mapping note: name-level 'Structural — GLP-1 / Private-Label Erosion' (24%) + 'Volume / Cost Recession' (18%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (42%); name-level 'Growth — Snacking + Premiumization' (18%) + 'Bull — Margin Recovery / Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 42% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $3B + PV(terminal) $8B = EV $11B; + net cash → equity $9B ÷ diluted shares 0.55B = $16/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $21/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 5% vs WACC 8% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $25; EV/Rev → $44.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 17x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-10-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.2% of revenue; cash conversion (OCF/NI) 177% — cash-backed.

Catalyst Calendar

• 2026-05-28 (~-41d) — Planters turnaround / snacking-portfolio update (authored)
• 2026-08-27 (~50d) — Quarterly earnings — est. EPS $0.36 (AV EARNINGS_CALENDAR)
• 2026-09-02 (~56d) — 'Transform & Modernize' cost-savings program milestone (authored)
• 2026-12-03 (~148d) — Q4 FY26 results + FY27 volume/price-mix guide (authored)

Forecast Track Record

• EPS surprise: beat 62.5% of the last 8 quarters; average surprise +1.6%.

Competitive Moat

Narrow moat. Hormel's moat rests on the SPAM/Skippy/Planters brand portfolio and turkey/protein scale, but private-label and GLP-1 demand pressure cap pricing power; a narrow moat justifies roughly the packaged-food median ~16-17x, not a premium — falsifiable if branded volumes keep ceding share to private label, which would argue for compression below 15x.

Moat sources:

• Iconic center-store brands (SPAM, Skippy, Planters, Jennie-O) with shelf-space and repeat purchase
• Vertically integrated turkey/protein supply chain and foodservice distribution
• Controlling Hormel Foundation ownership enabling long-term capital patience
• No pricing moat vs private label in commoditizing protein categories

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 15.8× forward EPS, vs the house DCF terminal 14.0×, and a peer median 16.56×. The house DCF sits 34% below spot, so the market is pricing in more than the house case — roughly 2.8pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 16.5× (simple median 16.56×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $20–$30, centre $24 (-1% vs spot); spot sits at the 47th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Margin Recovery / Re-Rate): $45.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (15.0); Revenue CAGR ±3pp (6.0); Terminal × ±15% (4.0); Capex intensity ±15% (4.0); WACC ±1pp (2.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 14×, FY+5 revenue $13B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Retail Foods (branded) organic volume growth < -0.03 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Two quarters of volume declining more than 3% would signal that GLP-1 calorie deflation and private-label switching are structural, not cyclical, and would validate the impairment scenario over the base.
• Non-GAAP operating margin < 0.082 (2 consecutive prints → Volume / Cost Recession). The base assumes margin recovers to roughly 8.8%. Two prints below 8.2% would put the earnings path on the recession track between the base and the structural case, given input-cost stickiness and under-absorbed plants.
• Full-year adjusted diluted EPS guidance midpoint < 1.5 (single event → Volume / Cost Recession). A cut of the full-year EPS guidance midpoint below roughly $1.50 would sit under the base-scenario earnings power and confirm the market is pricing a durable step-down rather than a transitory volume dip.
• Free cash flow dividend coverage (FCF / dividends paid) < 1.0 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). The dividend is the core of the thesis for a Dividend King. Two years of free cash flow failing to cover the payout, as capex ramps toward the ~4%-of-revenue schedule, would strain the balance sheet given the $2.0bn net-debt position and threaten the payout narrative.
• Trailing capital expenditure (annual) > 0.55 (single event → Base — Price/Mix Offsets Volume). Annual capex above roughly $0.55bn would run ahead of the top of the modelled glidepath and, absent a matching volume response, would dilute incremental returns on capital and undercut the disciplined-allocation assumption in the base case.

Fact / Inference / Speculation

• FACT: Spot $25; 52-week range $20–$30; engine rating HOLD; base-case target $25 (+3%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $21 (-15% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $21 (-15% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.